| Product Code: ETC071143 | Publication Date: Jun 2023 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The India Infectious Disease Biomarker Testing Market was estimated at USD 954 Million in 2025 and is projected to reach USD 1373 Million by 2032, growing at a CAGR of 5.3% from 2026 to 2032. This growth is primarily driven by the increasing incidence of chronic infectious diseases, such as HIV/AIDS, malaria, and tuberculosis, necessitating advanced diagnostic solutions. Additionally, the ongoing technological advancements and greater emphasis on personalized medicine further fuel the demand for biomarker testing within the Indian healthcare landscape.
The India Infectious Disease Biomarker Testing market has shown a notable recovery and growth over the past few years, rebounding from a contraction of -3.3% in 2021 due to pandemic-related disruptions. As consumer demand surged and healthcare technologies advanced, the market experienced a robust 9.0% growth in 2022 and continued strong performance into 2023 with an 8.0% increase. This upward trend is supported by escalating investments in healthcare infrastructure and innovations in diagnostic technologies. Projected growth rates of 7.3% in both 2024 and 2025 reflect the ongoing demand for precision medicine and enhanced disease surveillance capabilities. However, as growth stabilizes, expected rates of 6.3% to 6.7% from 2026 to 2032 indicate a maturing market landscape, driven by steady technology adoption and shifting healthcare policies.
This graph highlights how the India Infectious Disease Biomarker Testing Market has steadily grown over the past five years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -3.3% | Increasing adoption of advanced technologies |
| 2022 | 9.0% | Rising electricity demand across industries |
| 2023 | 8.0% | Increasing smart city development projects |
| 2024 | 7.3% | Government infrastructure modernization initiatives |
| 2025 | 7.3% | Rising electricity demand across industries |
| 2026 | 8.0% | Rapid growth in telecom and data center sectors |
| 2027 | 6.3% | Growing renewable energy integration projects |
| 2028 | 6.3% | Growing renewable energy integration projects |
| 2029 | 6.6% | Rising electricity demand across industries |
| 2030 | 6.5% | Expansion of transportation and logistics networks |
| 2031 | 6.7% | Expansion of transportation and logistics networks |
| 2032 | 6.4% | Expansion of transportation and logistics networks |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The most significant force shaping the India Infectious Disease Biomarker Testing Market is the growing prevalence of chronic infections, which necessitates sophisticated diagnostic tests for early detection. As a result, patients and healthcare providers are increasingly turning to biomarker testing as a reliable solution to manage and monitor these diseases.
In tandem with rising disease prevalence, supportive government initiatives aimed at bolstering healthcare infrastructure play a crucial role in shaping the market. Increased public awareness of preventive healthcare measures, combined with a push for research and development, is expected to propel the market forward over the coming years.
Despite the promising growth trajectory, the India Infectious Disease Biomarker Testing Market faces notable restraints. Limited access to test kits and reagents presents a significant barrier, particularly in rural areas where healthcare infrastructure is still underdeveloped. This scarcity not only hampers testing capabilities but also exacerbates inequalities in healthcare access among low-income groups. Additionally, the lack of a sufficiently skilled workforce poses a challenge, as the availability of adequately trained professionals is crucial for the effective execution of advanced diagnostic techniques.
A significant trend influencing the market is the growing preference for home-based diagnostics, driven by the desire to avoid long waiting times and reduce the burden on healthcare facilities. Patients are increasingly opting for remote testing solutions that provide them with timely and accurate results in the comfort of their homes. Moreover, continuous advancements in molecular techniques, such as Next Generation Sequencing and PCR, are expected to revolutionize the accuracy and efficiency of infectious disease diagnosis, thereby shaping future market dynamics.
The landscape of the India Infectious Disease Biomarker Testing Market presents numerous growth opportunities, particularly in the realm of innovative testing solutions. Increased investment in research and development is expected to yield novel biomarker tests that can cater to emerging infectious diseases. Furthermore, there lies a considerable opportunity in expanding diagnostic services in rural and underserved areas, where the demand for accessible and accurate testing remains high.
The Indian government has implemented several initiatives aimed at improving healthcare infrastructure and increasing public health awareness regarding infectious diseases. Programs focused on funding research activities and promoting the adoption of bio-molecular technologies are instrumental in enhancing diagnostic capabilities. Furthermore, the government’s commitment to strengthening healthcare delivery systems ensures that essential diagnostic services reach all segments of the population, particularly those in remote locations.
Looking ahead, the India Infectious Disease Biomarker Testing Market is poised for significant advancements from 2026 to 2032. The increasing burden of infectious diseases, paired with escalating healthcare investments, is expected to create a conducive environment for the growth of innovative diagnostic technologies. As consumer preferences shift towards personalized healthcare solutions and home-based testing, market players are likely to innovate rapidly, shaping a future that is more responsive to patient needs and public health challenges.
Recent developments within the India Infectious Disease Biomarker Testing Market have highlighted a focus on integrating advanced technologies into diagnostic processes. Companies and research institutions are increasingly collaborating to enhance testing capabilities and streamline operations. Furthermore, there is a concerted effort to improve supply chain efficiencies, ensuring that essential testing kits and reagents are more readily available across both urban and rural healthcare settings. These trends indicate a progressive shift towards more integrated and efficient diagnostic solutions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Infectious Disease Biomarker Testing Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Infectious Disease Biomarker Testing Market Revenues & Volume, 2022 & 2032F |
3.3 India Infectious Disease Biomarker Testing Market - Industry Life Cycle |
3.4 India Infectious Disease Biomarker Testing Market - Porter's Five Forces |
3.5 India Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 India Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.7 India Infectious Disease Biomarker Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 India Infectious Disease Biomarker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in India |
4.2.2 Technological advancements in biomarker testing leading to improved accuracy and efficiency |
4.2.3 Rising awareness about the importance of early disease detection and personalized medicine |
4.3 Market Restraints |
4.3.1 Limited access to advanced biomarker testing technologies in remote areas |
4.3.2 High cost associated with biomarker testing limiting adoption rates |
4.3.3 Regulatory challenges and lack of standardized guidelines for biomarker testing in India |
5 India Infectious Disease Biomarker Testing Market Trends |
6 India Infectious Disease Biomarker Testing Market, By Types |
6.1 India Infectious Disease Biomarker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Product, 2022-2032F |
6.1.3 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2022-2032F |
6.1.4 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Instruments, 2022-2032F |
6.1.5 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Services and Software, 2022-2032F |
6.2 India Infectious Disease Biomarker Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Immunodiagnostics, 2022-2032F |
6.2.3 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Clinical Microbiology, 2022-2032F |
6.2.4 India Infectious Disease Biomarker Testing Market Revenues & Volume, By PCR, 2022-2032F |
6.2.5 India Infectious Disease Biomarker Testing Market Revenues & Volume, By INAAT, 2022-2032F |
6.2.6 India Infectious Disease Biomarker Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2022-2032F |
6.2.7 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Other Technologies, 2022-2032F |
6.3 India Infectious Disease Biomarker Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Physician Offices, 2022-2032F |
6.3.3 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Reference Laboratories, 2022-2032F |
6.3.4 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.5 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Academic and Research Institutes, 2022-2032F |
6.3.6 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Others, 2022-2032F |
7 India Infectious Disease Biomarker Testing Market Import-Export Trade Statistics |
7.1 India Infectious Disease Biomarker Testing Market Export to Major Countries |
7.2 India Infectious Disease Biomarker Testing Market Imports from Major Countries |
8 India Infectious Disease Biomarker Testing Market Key Performance Indicators |
8.1 Rate of adoption of biomarker testing technologies in healthcare facilities |
8.2 Number of research and development collaborations for biomarker discovery and testing |
8.3 Percentage increase in government funding for infectious disease biomarker research and testing |
9 India Infectious Disease Biomarker Testing Market - Opportunity Assessment |
9.1 India Infectious Disease Biomarker Testing Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 India Infectious Disease Biomarker Testing Market Opportunity Assessment, By Technology, 2022 & 2032F |
9.3 India Infectious Disease Biomarker Testing Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 India Infectious Disease Biomarker Testing Market - Competitive Landscape |
10.1 India Infectious Disease Biomarker Testing Market Revenue Share, By Companies, 2025 |
10.2 India Infectious Disease Biomarker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here